NCT02078024View on ClinicalTrials.gov

Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana

PHASE3CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 25, 2018

Conditions
Onchocerciasis
Interventions
DRUG

IVM plus ALB

DRUG

IVM

Trial Locations (1)

Unknown

Onchocerciasis Chemotherapy Research Centre, (OCRC) Municipal Hospital, Hohoe

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT02078024 - Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana | Biotech Hunter | Biotech Hunter